• OPEN AN ACCOUNT
Indian Indices
Sensex
71,909.70 -570.59
( -0.79%)
Global Indices
Nasdaq
50,945.10 -425.82
(-0.83%)
Dow Jones
7,674.56 -17.28
(-0.22%)
Hang Seng
68,949.71 2,195.99
(3.29%)
Nikkei 225
10,610.72 -25.99
(-0.24%)
Forex
USD-INR
95.97 0.01
(0.01%)
EUR-INR
108.89 -0.26
(-0.24%)
GBP-INR
126.98 -0.19
(-0.15%)
JPY-INR
0.61 0.00
(0.01%)

EQUITY - MARKET SCREENER

Karnavati Finance Ltd
Industry :  Finance & Investments
BSE Code
ISIN Demat
Book Value()
538928
INE554R01020
0.4304876
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
18.86
13.27
EPS(TTM)
Face Value()
Div & Yield %
0.07
1
0
 

Bal Pharma consolidated net profit declines 33.89% in the March 2026 quarter
May 28,2026
Net profit of Bal Pharma declined 33.89% to Rs 3.59 crore in the quarter ended March 2026 as against Rs 5.43 crore during the previous quarter ended March 2025. Sales rose 2.69% to Rs 84.08 crore in the quarter ended March 2026 as against Rs 81.88 crore during the previous quarter ended March 2025.

For the full year,net profit declined 13.02% to Rs 6.28 crore in the year ended March 2026 as against Rs 7.22 crore during the previous year ended March 2025. Sales rose 2.83% to Rs 311.66 crore in the year ended March 2026 as against Rs 303.08 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales84.0881.88 3 311.66303.08 3
OPM %12.579.33 -10.249.75 -
PBDT6.284.77 32 17.0114.91 14
PBT3.222.59 24 5.935.14 15
NP3.595.43 -34 6.287.22 -13